Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

120.34
Delayed Data
As of Mar 27
 +2.74 / +2.33%
Today’s Change
59.79
Today|||52-Week Range
136.33
+1.30%
Year-to-Date

Today’s Trading

Previous close117.60
Today’s open117.73
Day’s range117.45 - 120.78
Volume1,618,094
Average volume (3 months)1,695,459
Market cap$29.1B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+50.17%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book27.06

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+1.65+1.00%
ZTSZoetis Inc+0.11+0.24%
ALXNAlexion Pharmaceutic...+4.55+2.58%
BMRNBiomarin Pharmaceuti...+13.23+11.45%
Data as of 4:03pm ET, 03/27/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account